For a good national and international strategy for corona vaccines

Summary

Measures to ensure social normality even without a vaccine; Presentation of a national Covid-19 vaccination strategy regarding effect, protective effect on target groups, priority distribution and vaccine safety, deployment to the EU regarding critical review of vaccine approval, ensuring worldwide cost-effective provision, fair distribution of and access to Corona products and intellectual property Property rights in accordance with WHO criteria and increasing production through non-exclusive licenses, supporting the application to the WTO to suspend patent protection, providing vaccine quotas for humanitarian emergencies and crisis situations, supporting the WHO-based patent pool (C-TAP) and financially increasing the COVAX Facility for the poorest countries (COVAX AMC)

Machine translation from German. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

2 official files

• 19/26573

  Drucksache · DE · 10 February 2021

  ViewDownloadOpen at official source

• 19/24362

  Drucksache · DE · 17 November 2020

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.